BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15973913)

  • 1. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease.
    Murphy EJ
    Anaesth Intensive Care; 2005 Jun; 33(3):311-22. PubMed ID: 15973913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
    Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
    Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of major analgesics in patients with renal dysfunction.
    Niscola P; Scaramucci L; Vischini G; Giovannini M; Ferrannini M; Massa P; Tatangelo P; Galletti M; Palumbo R
    Curr Drug Targets; 2010 Jun; 11(6):752-8. PubMed ID: 20041843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.
    King S; Forbes K; Hanks GW; Ferro CJ; Chambers EJ
    Palliat Med; 2011 Jul; 25(5):525-52. PubMed ID: 21708859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of opioids in liver disease.
    Tegeder I; Lötsch J; Geisslinger G
    Clin Pharmacokinet; 1999 Jul; 37(1):17-40. PubMed ID: 10451781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
    Vieira C; Brás M; Fragoso M
    Acta Med Port; 2019 May; 32(5):388-399. PubMed ID: 31166900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opioids in patients with renal impairment].
    Pfefferkorn F; Harings-Kaim A; Schönenberger M; Leuppi-Taegtmeyer A
    Ther Umsch; 2020; 77(1):10-13. PubMed ID: 32486992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of opioids in renal dysfunction.
    Davies G; Kingswood C; Street M
    Clin Pharmacokinet; 1996 Dec; 31(6):410-22. PubMed ID: 8968655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of chronic pain: a clinician's perspective.
    Cherry DA; Gourlay GK
    Agents Actions; 1994 Oct; 42(3-4):173-4. PubMed ID: 7879706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of atracurium and its metabolites.
    Ward S; Weatherley BC
    Br J Anaesth; 1986; 58 Suppl 1():6S-10S. PubMed ID: 3754756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease.
    Wise R; Wright N; Wills PJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):526-31. PubMed ID: 6264849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy with opioids in liver or renal failure].
    Tegeder I; Geisslinger G; Lötsch J
    Schmerz; 1999 Jun; 13(3):183-95. PubMed ID: 12799931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids in renal failure and dialysis patients.
    Dean M
    J Pain Symptom Manage; 2004 Nov; 28(5):497-504. PubMed ID: 15504625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children.
    Davis PJ; Stiller RL; Cook DR; Brandom BW; Davis JE; Scierka AM
    Anesth Analg; 1989 May; 68(5):579-83. PubMed ID: 2497657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain management in patients with liver cirrhosis].
    Ojeda A; Moreno LA
    Gastroenterol Hepatol; 2014 Jan; 37(1):35-45. PubMed ID: 24309482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographics, assessment and management of pain in the elderly.
    Davis MP; Srivastava M
    Drugs Aging; 2003; 20(1):23-57. PubMed ID: 12513114
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.